# Study of Ketamine as an Antidepressant in Major Depressive Disorder

> **NCT01573741** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Shi Jinyun** · enrollment: 35 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT01573741
- **Lead sponsor:** Shi Jinyun
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2012-12
- **Final completion:** 2013-02
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2012-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01573741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01573741, "Study of Ketamine as an Antidepressant in Major Depressive Disorder". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01573741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*